Drug Channels

MARCH 7, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m. to 1:30 p.m.

Pharmacy 84

Pharmacy Drugs Marketing 84

Drug Channels

DECEMBER 15, 2022

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channels Outlook 2023. Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market.

Marketing 88

Marketing Drugs Research Pharmacy 88

Drug Channels

MAY 23, 2023

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. d/b/a Drug Channels Institute.

Pharmacy 94

Pharmacy Marketing Drugs 94

Drug Channels

MARCH 29, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBM Industry Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. d/b/a Drug Channels Institute. to 1:30 p.m.

Specialty Pharmacies 73

Specialty Pharmacies Pharmacy Marketing Drugs 73

Drug Channels

MAY 22, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding This event will be broadcast live on Friday, June 23, 2023, from 12:00 p.m. to 1:30 p.m.

Pharmacy 73

Pharmacy Drugs Marketing Therapies 73

Drug Channels

SEPTEMBER 25, 2024

Drug Channel Institute is pleased to announce The Drug Channels 2025 Video Webinar Series. Fein for three live video webinars during 2025. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. drug channel.

Drugs 52

Drugs Marketing 52

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription dispensing revenues reached $621 billion in 2023, driven by accelerating GLP-1 prescriptions and an expanding post-pandemic market. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 81

Pharmacy Marketing Drugs 81

Drug Channels

JULY 12, 2022

Despite what you may have heard, pharmacy participation in the 340B Drug Pricing Program continues to thrive. Drug Channels Institute’s latest analysis reveals that an astonishing 32,000 pharmacy locations —more than half of the entire U.S. d/b/a Drug Channels Institute. Read on for details and my commentary below.

Pharmacy 87

Pharmacy Marketing Hospitals Drugs 87

Drug Channels

SEPTEMBER 20, 2023

Drug Channel Institute is pleased to announce The Drug Channels 2024 Video Webinar Series. Fein for three live video webinars during 2024. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. drug channel.

Drugs 52

Drugs Marketing 52

Drug Channels

NOVEMBER 15, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2022. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. The Outlook 2022 marks our third annual outlook webinar.

Specialty Pharmacies 52

Specialty Pharmacies Biosimilars Drugs Pharmacy 52

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. All rights reserved.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Fierce BioTech

JANUARY 9, 2024

This webinar provides a roadmap for organizations seeking to marry scientific excellence with market access acumen, driving transformative change for the benefit of patients. Listing Image QuartzListingLogo_250x190_clarivate.png Listing Introduction From R&D Promise to In-market Wins. Click here to login.

Marketing 52

Marketing Drugs Science Disease 52

Drug Channels

JUNE 1, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest live video webinar: Drug Channels Update: 340B Controversies and Outlook. This event is part of The Drug Channels 2021 Quarterly Video Webinar Series. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Drugs Marketing 52

Drug Channels

MARCH 8, 2023

Next week, Drug Channels Institute will release our 2023 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. How will GoodRx and Mark Cuban Cost Plus Drug Company affect the pharmacy industry? d/b/a Drug Channels Institute. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 87

Pharmacy Specialty Pharmacies Marketing Drugs 87

Alta Sciences

FEBRUARY 8, 2024

The FDA guidance, Evaluating Drug Effects on the Ability to Operate a Motor Vehicle , indicates that testing in early-phase clinical development should emphasize sensitivity over specificity in CNS effects. In this on-demand webinar, Ingrid Holmes , Vice President of Global Clinical Operations at Altasciences, and Dr. Gary G.

Clinical Trials 52

Clinical Trials Trials Clinical Pharmacology Clinical Development 52

Drug Channels

JUNE 20, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program.

Marketing 65

Marketing Pharmacy Drugs 65

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. d/b/a Drug Channels Institute. healthcare spending. to 1:30 p.m.

Pharmacy 93

Pharmacy Drugs Government Pharmaceuticals 93

Drug Channels

SEPTEMBER 14, 2020

Fein, CEO of Drug Channels Institute (DCI), for five live video webinars—one every calendar quarter, starting in the fourth quarter of 2020. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. d/b/a Drug Channels Institute.

Drugs 52

Drugs Marketing 52

Drug Channels

SEPTEMBER 7, 2022

As regular readers know, the biosimilar boom for provider-administered drugs has been accelerating. In many therapeutic areas, biosimilars’ market share is approaching 80%. That’s when Humira, the best-selling drug in the U.S., d/b/a Drug Channels Institute. Prices are dropping while adoption accelerates.

Biosimilars 88

Biosimilars Marketing Drugs Production 88

Drug Channels

DECEMBER 12, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2023. During Friday’s webinar, I’ll be sharing my updated thoughts about the IRA’s impact on manufacturers, Part D plans, and patient behavior. d/b/a Drug Channels Institute. 117-169).

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Drug Channels

APRIL 5, 2022

The highly-consolidated PBM market notched another year of increased concentration. Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. Significant business relationships among the largest companies continue to shift market share.

Pharmacy 94

Pharmacy Marketing Drugs 94

Drug Channels

DECEMBER 17, 2020

This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Drug Channels Outlook 2021. Drug pricing perceptions always seem to lag reality. The biosimilar market is finally beginning to fulfill its promise. d/b/a Drug Channels Institute.

Biosimilars 52

Biosimilars Marketing Regulations FDA 52

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending.

Pharmacy 85

Pharmacy Drugs Government Pharmaceuticals 85

The Pharma Data

JANUARY 6, 2021

Next-generation digital technologies are having an immense impact on the drug discovery process. The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab.

Cell Based Assays 52

Cell Based Assays Compound Screening Organic Chemistry DNA 52

Drug Channels

AUGUST 1, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. d/b/a Drug Channels Institute. Click here if you can’t see the video below.

Marketing 78

Marketing Drugs 78

Alta Sciences

JULY 17, 2023

Webinar—Determining the Right Regulatory Pathway for Your Drug iianiro Mon, 07/17/2023 - 16:57 Image EPR (2).png png URL [link] Description Save the date—Join Altasciences and tranScript for a complimentary webinar addressing the different regulatory pathways available to get your drug to market as quickly and safely as possible.

Drugs 40

Drugs Marketing 40

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D.,

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

OCTOBER 2, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D.,

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

JULY 20, 2022

Join me next week for my new live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook , on July 29, 2022, from 12:00 p.m. I’ll cover market trends, payer strategies, channel developments, key trends that will help you plan for the future, and more. d/b/a Drug Channels Institute. to 1:30 p.m.

Biosimilars 81

Biosimilars Pharmacy Drugs Marketing 81

Drug Channels

JULY 25, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. The highly-consolidated PBM market notched another year of increased concentration. d/b/a Drug Channels Institute.

Pharmacy 85

Pharmacy Marketing Drugs 85

Drug Channels

JUNE 21, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. We estimate that the gross-to-net bubble reached $223 billion for patent-protected brand-name drugs in 2022. d/b/a Drug Channels Institute.

Marketing 61

Marketing Pharmacy Drugs 61

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. One important update to the figures below: We (and many others) had significantly underestimated Walgreens' revenues and market share. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

OCTOBER 5, 2023

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs. d/b/a Drug Channels Institute. Click here if you can’t see the video below.

Pharmaceuticals 77

Pharmaceuticals Drugs Marketing 77

Drug Channels

JUNE 17, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

DECEMBER 13, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. d/b/a Drug Channels Institute. Click here to see the original post and comments from August 2021.

Pharmacy 89

Pharmacy Marketing Drugs 89

Drug Channels

JANUARY 21, 2022

Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. On February 22nd at 1:00 pm ET, ConnectiveRx will host Four Big Implications for Patients and the Prescription Journey in 2022 , a free webinar about the pandemic’s impact on key healthcare stakeholders. Read on for Chris’ insights.

Pharmacy 86

Pharmacy Marketing Drugs 86